Eliem Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Eliem Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
Eliem Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 2.3 %, a 47.9% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	2.3	-2.12	-47.9%	Jun 30, 2024
Q1 2024	2.89	-2.07	-41.8%	Mar 31, 2024
Q4 2023	3.33	-1.66	-33.3%	Dec 31, 2023
Q3 2023	3.9	-0.72	-15.6%	Sep 30, 2023
Q2 2023	4.42	+0.25	+5.99%	Jun 30, 2023
Q1 2023	4.95	-0.54	-9.83%	Mar 31, 2023
Q4 2022	4.98			Dec 31, 2022
Q3 2022	4.62			Sep 30, 2022
Q2 2022	4.18			Jun 30, 2022
Q1 2022	5.49			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.